We are live on ! Find out more
Financial Consulate

Financial Consulate Portfolio holdings

AUM $899M Turnover 31.89%
1-Year Est. Return 14.82%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+14.82%
3 Year Est. Return
+61.38%
5 Year Est. Return
+47.67%
10 Year Est. Return
+187.17%
AUM
$899M
AUM Growth
+$246K
Cap. Flow
-$5.85M
Cap. Flow %
-0.65%
Top 10 Hldgs %
64.64%
Holding
1,991
New
539
Increased
500
Reduced
311
Closed
96
Avg Time Held
0.7 years
Top 10 Avg Time Held
3.8 years
Top 20 Avg Time Held
2.9 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CXW icon
1651
CoreCivic
CXW
$2.97B
$226 ﹤0.01%
+7
New +$227
2026 Q3
0 quarters
MIR icon
1652
Mirion Technologies
MIR
$3.69B
$226 ﹤0.01%
+16
New +$253
2026 Q3
0 quarters
CHEF icon
1653
Chefs' Warehouse
CHEF
$4.32B
$225 ﹤0.01%
+2
New +$213
2026 Q3
0 quarters
VGNT icon
1654
Versigent PLC
VGNT
$2.93B
$225 ﹤0.01%
5
+4
+400% +$178
2026 Q2
1 quarter
AMRX icon
1655
Amneal Pharmaceuticals
AMRX
$7.1B
$222 ﹤0.01%
+11
New +$198
2026 Q3
0 quarters
CE icon
1656
Celanese
CE
$5.24B
$222 ﹤0.01%
+5
New +$228
2026 Q3
0 quarters
CUBI icon
1657
Customers Bancorp
CUBI
$2.86B
$222 ﹤0.01%
+3
New +$236
2026 Q3
0 quarters
IPAR icon
1658
Interparfums
IPAR
$3.69B
$222 ﹤0.01%
+2
New +$236
2026 Q3
0 quarters
QTWO icon
1659
Q2 Holdings
QTWO
$4.33B
$222 ﹤0.01%
+4
New +$237
2026 Q3
0 quarters
NHC icon
1660
National Healthcare
NHC
$3.7B
$220 ﹤0.01%
+1
New +$222
2026 Q3
0 quarters
ANIP icon
1661
ANI Pharmaceuticals
ANIP
$1.67B
$218 ﹤0.01%
+3
New +$231
2026 Q3
0 quarters
APAM icon
1662
Artisan Partners
APAM
$2.38B
$217 ﹤0.01%
+6
New +$237
2026 Q3
0 quarters
STEP icon
1663
StepStone Group
STEP
$3.46B
$217 ﹤0.01%
+5
New +$233
2026 Q3
0 quarters
MTZ icon
1664
MasTec
MTZ
$13.7B
$214 ﹤0.01%
1
-2
-67% -$562
2026 Q1
2 quarters
NMG icon
1665
Nouveau Monde Graphite
NMG
$310M
$213 ﹤0.01%
177
– –
2025 Q4
3 quarters
BANF icon
1666
BancFirst
BANF
$3.74B
$211 ﹤0.01%
+2
New +$225
2026 Q3
0 quarters
BFS icon
1667
Saul Centers
BFS
$725M
$211 ﹤0.01%
+7
New +$236
2026 Q3
0 quarters
EPAC icon
1668
Enerpac Tool Group
EPAC
$1.83B
$210 ﹤0.01%
+6
New +$216
2026 Q3
0 quarters
TTWO icon
1669
Take-Two Interactive
TTWO
$38.1B
$208 ﹤0.01%
1
-4
-80% -$925
2025 Q3
4 quarters
FIVN icon
1670
FIVE9
FIVN
$2.81B
$205 ﹤0.01%
+6
New +$182
2026 Q3
0 quarters
SIG icon
1671
Signet Jewelers
SIG
$4.49B
$205 ﹤0.01%
+2
New +$183
2026 Q3
0 quarters
VAC icon
1672
Marriott Vacations Worldwide
VAC
$3.76B
$205 ﹤0.01%
+2
New +$209
2026 Q3
0 quarters
BLDP icon
1673
Ballard Power Systems
BLDP
$516M
$204 ﹤0.01%
100
– –
2025 Q3
4 quarters
DNOW icon
1674
DNOW Inc
DNOW
$2.84B
$202 ﹤0.01%
+13
New +$195
2026 Q3
0 quarters
UDR icon
1675
UDR
UDR
$11.5B
$202 ﹤0.01%
6
-8
-57% -$300
2026 Q2
1 quarter

Similar funds

Financial Consulate's Q3 2026 Portfolio in Review

As of Q3 2026, Financial Consulate held 1,991 positions worth $899M, up 0.03% from $899M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Financial Consulate's Q3 2026 filing shows 539 new, 500 increased, 311 reduced and 96 closed positions. Its largest new stake was SK Hynix Inc: 702 shares worth $129K. The largest sale was 10x Genomics, an estimated $3.46M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, down from 85% a quarter earlier, followed by Technology and Financials.

  • Financial Consulate's largest Q3 2026 buy was SK Hynix Inc: 702 shares worth $129K.
  • Financial Consulate added most to iShares 0-1 Year Treasury Bond ETF in Q3 2026, an estimated $619K increase.
  • Financial Consulate's biggest Q3 2026 reduction was 10x Genomics, cutting an estimated $3.46M.
  • Financial Consulate fully exited iShares National Muni Bond ETF in Q3 2026, selling an estimated $135K.
  • Financial Consulate's ten largest holdings make up 65% of its $899M portfolio in Q3 2026.
  • Financial Consulate opened 539 new positions and closed 96 in Q3 2026.
  • Financial Consulate's portfolio value rose 0.03% quarter-over-quarter to $899M.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.